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ABSTRACT Interactions of two antimicrobial peptides, magainin 2 and indolicidin, with three different model biomembranes,
namely, monolayers, large unilamellar vesicles (LUVs), and giant liposomes, were studied. Insertion of both peptides into lipid
monolayers was progressively enhanced when the content of an acidic phospholipid, 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoglycerol (POPG) in a film of 1-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (SOPC) was increased. Indolicidin and
magainin 2 penetrated also into lipid monolayers containing cholesterol (mole fraction, X  0.1). Membrane association of
magainin 2 attenuated lipid lateral diffusion in POPG-containing LUVs as revealed by the decrease in the excimer/monomer
fluorescence ratio Ie/Im for the pyrene fatty-acid-containing phospholipid derivative 1-palmitoyl-2-[10-(pyren-1-yl) decanoyl]-
sn-glycero-3-phospho-rac-glycerol (PPDPG). Likewise, an increase in steady-state fluorescence anisotropy of the mem-
brane-incorporated diphenylhexatriene (DPH) was observed, revealing magainin 2 to increase acyl chain order and induce
segregation of acidic phospholipids. Similar effects were observed for indolicidin. The topological effects of magainin 2 and
indolicidin on phospholipid membranes were investigated using optical microscopy of giant vesicles. Magainin 2 had
essentially no influence on either SOPC or SOPC:cholesterol (X  0.1) giant liposomes. However, effective vesiculation was
observed when acidic phospholipid (XPG  0.1) was included in the giant vesicles. Indolicidin caused only a minor shrinkage
of giant SOPC vesicles whereas the formation of endocytotic vesicles was observed when the giant liposome contained
POPG (XPG  0.1). Interestingly, for indolicidin, vesiculation was also observed for giant vesicles composed of SOPC/
cholesterol (Xchol  0.1). Possible mechanisms of membrane transformation induced by these two peptides are discussed.
INTRODUCTION
During the last decade an increasing number of antimicro-
bial peptides, such as cecropins, defensins, magainins,
melittin, indolicidin, and alamethicin, have been discovered
in animals and plants as well as bacteria. These peptides
serve in the vertebrates and invertebrates for both offensive
and defensive purposes (Sansom, 1991; Saberwal and Na-
garaj, 1994; Matsuzaki, 1998) by interacting with the lipids
and somehow disturbing the barrier properties of the mem-
branes of the target cells (Bechinger, 1997; Matsuzaki,
1998, 1999; Oren and Shai, 1998; Shai, 1999; Sitaram and
Nagaraj, 1999). Being cationic, antimicrobial peptides in-
teract preferentially with acidic lipids, which are particu-
larly abundant in bacteria (Op den Kamp, 1979), thus pro-
viding the basis for differences in cell specificity
(Matsuzaki et al., 1995a). The above characteristics make
these peptides an interesting area for studies on lipid-protein
interactions and may further allow for developing novel
antimicrobial, anticancer, and antiviral compounds.
We report here on a comparison of the interactions with
lipid membranes of two antimicrobial peptides, magainin 2
and indolicidin. Magainin and indolicidin belong to differ-
ent antimicrobial peptide families classified by their amino
acid composition and secondary structure (Falla et al.,
1996). Accordingly, magainin is a paradigm of the group
that assumes an amphipathic -helical structure in lipid
membranes (Matsuzaki, 1999), whereas indolicidin belongs
to another group with a unique amino acid composition and
a non--helical conformation in lipid bilayers (Ladokhin et
al., 1999; Ha et al., 2000). Magainins were discovered in the
skin of the African clawed frog Xenopus laevis and show a
broad spectrum of antimicrobial (Zasloff, 1987; Zasloff et
al., 1988) and anticancer cell activities (Cruciani et al.,
1991; Baker et al., 1993) at nonhemolytic concentrations.
To this end, it is of interest that extracts of frog skin have
been used in traditional Chinese medicine for the control of
skin infections (L. Miao, University of Roskilde, personal
communication, 2000). Magainin 2 consists of 23 amino
acid residues (GIGKFLHSAKKFGKAFVGEIMNS), has a
positive net charge of 4, and exerts its antimicrobial
activity by permeabilizing the bacterial membrane (Matsu-
zaki et al., 1997). It has been proposed that a peptide-lipid
supramolecular complex pore is formed, allowing for trans-
bilayer traffic of ions, lipids, and peptides, with simulta-
neous dissipation of transmembrane potential and lipid
asymmetry (Matsuzaki et al., 1995a,b,c, 1996, 1998; Ludtke
et al., 1996). Spectroscopic and kinetic studies on the effects
of magainin on submicroscopic lipid vesicles (Matsuzaki et
al., 1995a,b,c, 1996, 1998; Ludtke et al., 1996) have re-
vealed the cooperative nature of the interactions. However,
the exact mechanisms of membrane perturbation by ma-
gainin remain controversial.
Indolicidin is found in cytoplasmic granules of bovine
neutrophils (Selsted et al., 1992) and has a unique amino
acid composition with five Trp and three Pro residues in its
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13-amino-acid sequence (ILPWKWPWWPWRR). It is one
of the shortest natural linear antimicrobial peptides and,
similarly to magainin, has activity against both Gram-neg-
ative and -positive bacteria (Selsted et al., 1992) and fungi
(Ahmad et al., 1995) as well as protozoa (Aley et al., 1994).
Indolicidin is cytotoxic also to rat and human T lympho-
cytes (Schluesener et al., 1993), lyses red blood cells (Ah-
mad et al., 1995), and has activity against HIV-1 (Robinson
et al., 1998). Indolicidin preferentially binds to acidic phos-
pholipid, although it also associates with neutral phospho-
lipids (Ladokhin et al., 1997). Indolicidin has been shown to
permeabilize the outer membrane of Escherichia coli (Falla
et al., 1996; Subbalakshmi et al., 1996) to form channels as
revealed by conductance measurements with planar bilayers
(Falla et al., 1996; Wu et al., 1999). Indolicidin’s high
affinity to membranes, unusual amino acid composition,
and small size make it an intriguing antimicrobial agent. Its
antimicrobial activity, the charge requirement, and also the
importance of Trp and Pro residues for biological activity
have been extensively studied (Sitaram and Nagaraj, 1999).
However, the molecular mechanisms underlying peptide-
mediated cell lysis, i.e., whether the peptide forms pores,
dissolves the membranes like a detergent, or induces mem-
brane defects, remain matters of debate (Sitaram and Naga-
raj, 1999).
Small and large unilamellar vesicles (LUVs) continue to
be widely exploited as model membranes. However, these
liposomes are submicroscopic and do not allow resolution
of morphological features relevant to more macroscopic
changes in biomembranes. The so-called giant vesicles (10–
500 m), which are spherical, closed molecular bilayers and
entrap an aqueous compartment, are instead good models
for studies of undulation, budding, wounding, healing, and
other manifestations of cell-like behavior induced by mem-
brane-acting reagents (Riquelme et al., 1990; Menger, 1998;
Menger and Lee, 1995; Menger and Keiper, 1998; Ange-
lova and Tsoneva, 1999; Angelova et al., 1999; Holopainen
et al., 2000). Due to their large size, giant vesicles can be
observed by light microscopy, permitting direct visualiza-
tion of processes involving supramolecular chemistry and
biophysics (Luisi and Walde, 2000). In this study, we used
different membrane models, namely, monolayers, large
unilamellar vesicles, and giant liposomes, respectively, to
investigate the penetration of magainin and indolicidin into
films, their effects on the dynamics of lipids in bilayers, and
macroscopic, morphological changes in membranes.
MATERIALS AND METHODS
Materials
Hepes, EDTA, and magainin 2 were from Sigma (St. Louis, MO) and
indolicidin from Bachem (Bubendorf, Switzerland). The purity of the
peptides were 99% and 95%, respectively, as verified by high-perfor-
mance liquid chromatography analysis provided by their respective sup-
pliers. The correct molecular weights and purity of magainin 2 and in-
dolicidin were confirmed by mass spectroscopy. 1-Stearoyl-2-oleoyl-sn-
glycero-3-phosphocholine (SOPC), 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoglycerol (POPG), and -cholesterol were from Avanti Polar Lipids
(Alabaster, AL). For the fluorescent phospholipid analogs, 1-palmitoyl-2-
[10-(pyren-1-yl)decanoyl]-sn-glycero-3-phospho-rac-glycerol (PPDPG)
and 1-palmitoyl-2-[10-(pyren-1-yl)decanoyl]-sn-glycero-3-phosphocho-
line (PPDPC) were from K&V Bioware (Espoo, Finland). Diphenyl-
hexatriene (DPH) was from EGA Chemie (Steinheim, Germany). Concen-
trations of the nonlabeled lipids were determined gravimetrically with a
high-precision electrobalance (Cahn, Cerritos, CA) and those of the
pyrene-containing phospholipids and DPH spectrophotometrically, by ab-
sorbance at 341 nm, using molar extinction coefficients of 38,000 cm1
and 88,000 cm1, respectively. The purity of the lipids was checked by thin
layer chromatography on silicic-acid coated plates (Merck, Darmstadt,
Germany) developed with chloroform/methanol/water (65:25:4, v/v/v).
Examination of the plates after iodine staining and, when appropriate, upon
UV illumination revealed no impurities.
Penetration of the peptides into lipid monolayers
Penetration of peptides into monomolecular lipid films was measured using
magnetically stirred circular Teflon wells (Multiwell plate, subphase vol-
ume 1.2 ml, Kibron, Helsinki, Finland). Surface pressure () was moni-
tored with a Wilhelmy wire attached to a microbalance (Delta Pi, Kibron)
connected to a Pentium PC. Lipids were mixed in the indicated molar ratios
in chloroform (1 mg/ml) and then spread in this solvent onto the air-
buffer (5 mM Hepes, 0.1 mM EDTA, pH 7.0) interface. Subsequently, the
lipid monolayers were allowed to equilibrate for 15 min at different
initial surface pressures (0) before the injection of magainin 2 or indolici-
din into the subphase. The final concentration of the peptides was 1 M.
The increments in  after the injection of peptides were complete in 30
min, and the difference between the initial surface pressure (0) and the
value observed after the penetration of peptides into the films was taken as
. The data shown represent averages from triplicate measurements and
are represented as  versus 0. All measurements were performed at
ambient temperature (24°C).
Preparation of LUVs
The indicated lipids were mixed in chloroform after which the solvents
were removed under a stream of nitrogen and the lipid residue subse-
quently maintained under reduced pressure for at least 2 h. The dry lipids
were then hydrated at 50°C to yield a lipid concentration of 1 mM. The
resulting dispersions were extruded through a stack of two polycarbonate
filters (100-nm pore size, Millipore, Bedford, MA) using a Liposofast-low-
pressure homogenizer (Avestin, Ottawa, Canada) to obtain LUVs.
Measurement of Ie/Im
Pyrene is a paradigm for excimer-forming organic fluorophores, and its
derivatives are widely exploited in studies on biomolecules. A monomeric
pyrene emits fluorescence with a wavelength at398 nm, and the excimer
(excited dimer) relaxes back to two ground-state pyrenes by emission with
a maximum at 480 nm. Steady-state Ie/Im values provide a reasonably
good measure of qualitative changes in the collision frequency of the
probes, mirroring both lateral diffusion and local concentration of the
pyrene-labeled lipids (for brief reviews, see Kinnunen et al., 1993; Dupor-
tail and Lianos, 1996). Fluorescence emission spectra for LUVs labeled
with PPDPG or PPDPC (X  0.01) were measured with a Perkin-Elmer
LS50B spectrofluorometer with a magnetically stirred, thermostatted cu-
vette compartment using excitation wavelength of 344 nm. Bandwidths of
5 nm were used for both excitation and emission. The lipid concentration
used was 25 M with temperature maintained at 25°C. After addition of
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appropriate amounts of peptides, samples were equilibrated for 5 min
before recording the spectra. Three scans were averaged, and the emission
intensities at 398 and 480 nm were taken for Im and Ie, respectively. All
measurements were repeated three times.
Fluorescence anisotropy of DPH
DPH was included into liposomes at X  0.002. The lipid concentration
used was 25 M with temperature maintained at 25°C. Polarized emission
was measured in L-format using Polaroid-type filters with Perkin-Elmer
LS50B. Fluorescence anisotropy r for DPH was measured with excitation
at 360 nm and emission at 450 nm, using 5nm bandwidths, and its values
were calculated using routines of the software provided by Perkin-Elmer.
All measurements were repeated three times.
Formation of giant liposomes
Giant liposomes were prepared as described elsewhere (Angelova and
Dimitrov, 1986; Holopainen et al., 2000). Briefly, 1–3 l of the desired
lipids dissolved in diethylether:methanol (9:1, v/v, final total lipid concen-
tration 1 mM) were spread on the surface of two Pt electrodes and
subsequently dried under a stream of nitrogen. Possible residues of organic
solvent were removed by evacuation in vacuum for 1 h. A glass chamber
with the attached electrodes and a quartz window bottom was placed on the
stage of a Zeiss IM-35 inverted fluorescence microscope. An AC field
(sinusoidal wave function with a frequency of 4 Hz and an amplitude of 0.2
V) was applied before adding 1.3 ml of 0.5 mM Hepes buffer, pH 7.4.
During the first minute of hydration the voltage was increased to 1.0–1.2
V. The AC field was turned off after 2–4 h, and giant liposomes were
observed with Hoffman modulation contrast (HMC) optics with a 10/
0.25 objective (Modulation Optics, New York, NY). The size of giant
liposomes was measured using calibration of the images by motions of the
micropipette as proper multiples of the step length (50 nm) of the micro-
manipulator (MX831 with MC2000 controller, SD Instruments, Grants
Pass, Oregon). Images were recorded with a Peltier-cooled 12-bit digital
CCD camera (C4742–95, Hamamatsu, Hamamatsu City, Japan) interfaced
to a computer and operated by the software (HiPic 5.0.1) provided by the
manufacturer.
Microinjection techniques
Micropipettes with inner tip diameters of 0.5 m (Schnorf et al., 1994)
were made from borosilicate capillaries (1.2-mm outer diameter) by a
microprocessor-controlled horizontal puller (P-87, Sutter Instrument Co.,
Novato, CA). Indicated amounts of the peptide solutions (0.5 mM in 10
mM Hepes, 0.1 mM EDTA, pH 7.0) were applied onto the outer surface of
individual giant vesicles as a series of single injections of 20 fl delivered
with a pneumatic microinjector (PLI-100, Medical Systems Corp., Green-
vale, NY). For easier handling only vesicles attached to the electrode
surface were used. All experiments were performed at ambient temperature
(24°C) and were repeated at least 10 times.
RESULTS
Penetration of the antimicrobial peptides into
lipid monolayers
The intercalation of the antimicrobial peptides into lipid
monolayers spread at the air/water interface to different
initial surface pressures (0) was observed by measuring the
increment in surface pressure () following the addition of
the peptides into the subphase (Brockman, 1999; Verger
and Pattus, 1976). Magainin 2 readily inserted into SOPC
monolayers at 0  12 mN/m (Fig. 1 A), whereas above 0
	 35 mN/m its penetration into the film was abolished, this
value thus representing the critical packing pressure c for
the interaction of this peptide with SOPC films. In keeping
with its net positive charge of 4 (Matsuzaki, 1998), the
penetration of magainin 2 into the lipid monolayer was
progressively augmented when the content of the acidic
phospholipid POPG in the film was increased (Fig. 1 A).
Accordingly, the values for c abrogating the intercalation
of magainin 2 into the monolayer were increased to 39
(XPG  0.1), 43 (XPG  0.2), and 46 mN/m (XPG  0.4)
(Fig. 1 C). Instead, the inclusion of cholesterol (Xchol 0.1)
into the SOPC film had no significant effect on the pene-
tration of magainin 2 (Fig. 1 A).
A pronounced increase in  was observed also for in-
dolicidin, revealing its insertion into the SOPC monolayers
(Fig. 1 B). However, indolicidin is significantly more mem-
brane active than magainin 2, with c 	 65mN/m for a film
of SOPC. Similarly to magainin 2, the presence of increas-
ing contents of POPG in the monolayer enhanced the pen-
etration of indolicidin, increasing  below 38 mN/m,
and in keeping with an electrostatic interaction between the
peptide and the lipid monolayer. However, above the latter
value for surface pressure the increment in  due to in-
dolicidin was attenuated by POPG. Thus, in contrast to
magainin 2, there was now a decrement in c in the pres-
ence of POPG (Fig. 1 C), shifting from 65 mN/m (for a
SOPC monolayer) to 50 mN/m at XPG  0.4. The incre-
ment in  by indolicidin was augmented also by cholesterol
(X  0.1) in a SOPC monolayer, whereas c decreased to
54 mN/m. The patterns evident in Fig. 1 for magainin 2
and indolicidin are very different, with a distinct crossover
point at 38 mN/m for the latter peptide.
Effects of the antimicrobial peptides on the lipid
dynamics in bilayers
Subsequently to the above monolayer studies it was of
interest to explore the impact of the peptides on lipid dy-
namics. This was accomplished using fluorescence spec-
troscopy and LUVs of varying lipid compositions, record-
ing emission spectra for the pyrene-labeled fluorescent
phospholipid analogs PPDPC or PPDPG (both at X 0.01).
For SOPC LUVs the addition of magainin 2 caused signif-
icant quenching of pyrene fluorescence, the intensities of
both pyrene monomer and excimer emission decreasing in
parallel, as shown for Im (Fig. 2). Consequences of the
association of magainin 2 with liposomes were studied also
as a function of XPG. Upon increasing XPG from 0.1 to 0.4,
progressively enhanced Im at 398 nm (RFIm) due to ma-
gainin 2 was observed whereas the initial increment in Im
leveled off at well defined PG/magainin 2 stoichiometries of
2, 3, and 5 (Fig. 2 A). Following this initial phase up to the
given stoichiometries there was a second process, the slope
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of which also increased with XPG (Fig. 2 B). Magainin 2
caused only insignificant changes in Ie/Im at XPG  0 and
0.1, whereas at XPG  0.2 and 0.4, decrements by 10% and
25%, respectively, were evident (Fig. 3 A). To distinguish
between two qualitatively different changes in lipid dynam-
ics, namely, lateral mobility and microdomain formation, as
underlying causes for the above changes in Ie/Im we also
assessed changes in acyl chain order by measuring fluores-
cence anisotropy r for DPH (Fig. 3 B). Magainin 2 caused
virtually no changes in r in the absence of the acidic
phospholipid (Fig. 3 B). However, progressively augmented
lipid packing and acyl chain order upon the addition of
magainin 2 were evident with increasing XPG (Fig. 3 B),
with maximally 1.4-fold increment in r at XPG  0.4.
Notably, lack of changes in Ie/Im at XPG 0.1 together with
the increase in acyl chain order reveal that microscopic
enrichment of PPDPG is taking place. Interestingly, in the
presence of cholesterol (Xchol  0.1), both Im and Ie de-
creased dramatically due to magainin 2, with insignificant
changes in Ie/Im (Figs. 2 A and 3 A). Enhanced membrane
order by the incorporation of cholesterol in the membrane is
revealed by the increase in r before the addition of the
peptide (Fig. 3 B), as reported previously (van Ginkel et al.,
1989). However, magainin 2 had no further effect on r in the
presence of cholesterol (Xchol  0.1, Fig. 3 B).
Subsequently, we carried out identical measurements
as above but using indolicidin. Similarly to magainin 2,
indolicidin also caused a parallel decrease in both Im and
Ie for SOPC LUVs, illustrated here for Im (Fig. 4 A).
However, in contrast to magainin 2, quenching of pyrene
fluorescence was evident also when the acidic phospho-
lipid POPG was present. When the peptide/lipid molar
ratio was 
1/20, Im decreased in the sequence XPG 
0.4 
 0.2 
 0.1 
 0. At XPG 0.4 and upon peptide/lipid
molar ratio 1:12.5 the values for Im decreased further.
The maximal decrement in Im due to indolicidin was from
15% (at XPG  0) to 40% (at XPG  0.4). Despite the
decrease in Im, Ie/Im revealed no significant changes due
to indolicidin (Fig. 4 B). Interestingly, the largest de-
crease in Im was measured at Xchol  0.1 (Fig. 4 A).
Similarly to magainin 2, DPH anisotropy r remained
constant when indolicidin was added to SOPC LUVs
(Fig. 5 A). However, augmented lipid packing and in-
creased acyl chain order were caused by indolicidin in
FIGURE 1 Penetration of antimicrobial peptides into lipid monolayers.
Increments in surface pressure () of lipid monolayers due to the addition
of 1 Mmagainin (A) or indolicidin (B) into the subphase are illustrated as
a function of the initial surface pressure (0). Content of the acidic POPG
(XPG) in SOPC was 0 (), 0.1 (f), 0.2 (F), and 0.4 (Œ). Also shown is the
insertion of the peptides into a SOPC film with Xchol  0.1 (). The
changes of c as a function of XPG upon the penetration of magainin ()
and indolicidin (*) are shown in C. Each data point represents the mean of
triplicate measurements. The standard deviation varied between 0.1 mN/m
and 0.8 mN/m and for the sake of clarity is not shown.
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acidic-phospholipid-containing membranes, evident as
an increase in r (Fig. 5 A). Moreover, the increase in r
depended on XPG, increasing with the content of the
acidic phospholipid in bilayers (Fig. 5 B). The corre-
sponding maximal increase was from 1.05- to 1.39-fold.
The increment in the membrane acyl chain order due to
indolicidin was observed also in the presence of choles-
terol, increasing r by 1.06-fold (Fig. 5 A).
Effects of antimicrobial peptides on
membrane topology
Because of the pronounced and lipid-composition-depen-
dent effects of magainin 2 and indolicidin on monolayers
and LUVs described above it was of interest to compare the
impact of these peptides on the three-dimensional topology
of macroscopic membranes using giant liposomes, both
with and without PG. Giant liposomes composed of SOPC
readily formed in an AC field. SOPC membranes were
unaffected by magainin 2 even when exposed to high
amounts of the peptide (2 fmol, 4 pl  200 repeated
injections, data not shown). Likewise, also giant liposomes
FIGURE 2 Effects of magainin on lipid dynamics in LUVs assessed by
fluorescence of pyrene-labeled phospholipid analogs (X  0.01), shown as
changes in pyrene monomer emission intensity Im	 398 nm (A) and slopes
for the increase in Im after reaching saturation response in RFIm (B).
PPDPC was used in SOPC and SOPC/cholesterol LUVs, and PPDPG in
LUVs containing POPG. Liposomes were composed of SOPC with XPG 
0 (), 0.1 (f), 0.2 (F), and 0.4 (Œ), and with Xchol  0.1 (). The
concentration of lipids was 25 M in a total volume of 2 ml of 5 mM
Hepes, 0.1 mM EDTA, pH 7.0. The temperature was maintained at 25°C
with a circulating waterbath. Each data point represents the mean of
triplicate measurements, with the error bars indicating SD.
FIGURE 3 Effects of magainin on excimer to monomer ratio R(Ie/Im) of
pyrene-labeled phospholipid analogs (A) and on the steady-state emission
anisotropy r of DPH (X  0.002) (B) in SOPC liposomes with XPG  0
(), 0.1 (f), 0.2 (F), and 0.4 (Œ) and with Xchol  0.1 (). Otherwise,
conditions were as described in the legend for Fig. 2.
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composed of SOPC and cholesterol (Xchol  0.1) were
unaffected by this quantity of magainin 2 (data not shown).
However, in the presence of POPG (XPG  0.1) already
0.01 fmol (a single 20-fl injection) of magainin 2 ap-
plied onto the surface of giant vesicles significantly affected
the topology of the giant liposome membrane (Fig. 6 B).
More specifically, in 1 min, small particles ( 	 0.9 m)
emerged inside the giant vesicle. Subsequent injections of
magainin 2 up to 0.1 fmol (in 200 fl) caused no further
visible changes. After the addition of a total of0.2 fmol of
the peptide, the membrane began to undulate and a dense
particle ( 	 4 m) became visible inside the giant lipo-
some (Fig. 6 C). In5 min, several small particles (	 0.9
m) emerged on the inner surface of the giant liposome
membrane (Fig. 6 D). Subsequently, most of these small
particles moved into the internal cavity of the giant vesicle.
These endocytotic vesicles appeared to move freely inside
the giant liposome, with no further changes during the
following 30 min of observation. Further injection of ma-
FIGURE 4 Effects of indolicidin on lipid dynamics in LUVs assessed by
pyrene-labeled phospholipid analogs, depicted as changes in pyrene mono-
mer emission intensity Im 	 398 nm (A) and excimer to monomer ratio
R(Ie/Im) (B). PPDPC was used in SOPC and SOPC/cholesterol LUVs and
PPDPG in LUVs containing POPG. Liposomes were composed of SOPC
with XPG  0 (), 0.1 (f), 0.2 (F), and 0.4 (Œ) and with Xchol  0.1 ().
Otherwise, conditions were as described in the legend for Fig. 2.
FIGURE 5 Effects of indolicidin on the steady-state emission anisotropy
r of DPH (X  0.002) (A) in SOPC liposomes with XPG  0 (f), 0.1 (),
0.2 (F), and 0.4 (Œ) and with Xchol  0.1 (Œ). The changes in r as a
function of XPG upon addition of 3.6 M indolicidin (f) are shown in B.
For comparison, the data for magainin 2 () are also shown. Otherwise,
conditions were as described in the legend for Fig. 2.
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gainin 2 delivering a total of 0.3 fmol of the peptide caused
an endocytosis-like process with the emergence of a dense
particle with a diameter of 8 m (Fig. 6 E). The number
of the 0.9-m particles inside the giant liposomes contin-
ued to increase after 10 min. Occasionally, these particles
emerged also on the outer surface of the giant vesicle and
were released into the external buffer (Fig. 6 E). Subsequent
addition of magainin 2 (0.7 fmol in total) destabilized the
membrane and induced further vesiculation (Fig. 6 F).
These endocytotic vesicles remained separated from each
other inside the giant liposome, and the size of the giant
vesicle decreased visibly (Fig. 6 F). Eventually, upon fur-
ther addition of magainin 2 (up to 1.5 fmol) the giant
liposome membrane collapsed. The above morphological
changes were highly reproducible.
Subsequently, we studied the effects of indolicidin on
giant liposomes composed of SOPC as well as of its mix-
tures with POPG (XPG  0.1). For SOPC giant liposomes
the only change evident was a minor shrinkage after the
application of 2 fmol (200 injections) of indolicidin
onto their surface (data not shown). However, when the
vesicle contained POPG (X  0.1), indolicidin (0.5 fmol)
induced an endocytosis-like process (Fig. 7) and small par-
ticles (  0.9 m) appeared inside the giant liposome.
After the addition of 0.5 fmol of indolicidin (50 injec-
tions) the area of the giant liposome surface exposed to
indolicidin became dark, revealing a pronounced change in
the refractive index and indicating the formation of a tightly
packed three-dimensional structure, remaining only partly
in the focal plane (Fig. 7 B). Small particles ( 	 0.9 m)
emerged inside the giant liposome within 1 min after the
FIGURE 6 HMC images of transformation induced by magainin of a
SOPC/POPG (XPG  0.1) giant liposome. Shown is a giant vesicle before
the addition of magainin (A), 1 min after the addition of 0.01 fmol of
magainin (B), after the addition of a total of 0.2 fmol of magainin (C),
after 5 min (D), 10 min after the addition of a total of 0.3 fmol of
magainin (E), and immediately after the addition of a total of 0.7 fmol of
magainin (F). The length of the scale bar in F corresponds to 20 m.
FIGURE 7 HMC images of transformation induced by indolicidin of a
SOPC/POPG (XPG  0.1) giant liposome. Shown is a giant vesicle before
the addition of the peptide (A) and immediately (B) and 1 min (C) after the
addition of 0.5 fmol of indolicidin. Subsequent images were taken
immediately (D), 1 min (E), and 2 min (F) after the addition of a total of
0.6 fmol of indolicidin. The length of the scale bar in F corresponds to
20 m.
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formation of the above aggregate (Fig. 7 C). The aggregate
on the surface of the membrane remained after the subse-
quent addition of another 0.1 fmol of indolicidin, with more
of the small-diameter particles emerging inside the giant
vesicle (Fig. 7, D–F). This endocytosis-like process was
repeated with subsequent addition of indolicidin, with pro-
gressive accumulation of a number of small particles inside
the giant liposome and with the size of the giant liposome
decreasing slightly.
Subsequently, we studied the impact of indolicidin on
giant liposomes composed of SOPC and cholesterol (Xchol
 0.1). Indolicidin caused vesiculation of giant liposome
also in the presence of cholesterol. The endocytotic vesicles
formed were profoundly aggregated on the surface of the
giant vesicle (Fig. 8 B). Specifically, within 5 s after the
addition of0.2 fmol of indolicidin (400 fl, 20 injections,
Fig. 8 B), a cluster of small particles emerged on the surface
of the giant liposome. Subsequently, the aggregate trans-
ferred into the giant liposome, while also a few endocytotic
particles ( 	 0.9 m) were visible. Further addition of
indolicidin increased the number of these particles and
caused shrinkage of the giant liposome. However, the mem-
brane remained macroscopically intact even when exposed
to 2 fmol of indolicidin (200 injections, data not shown).
DISCUSSION
Membrane activities of magainin 2 and indolicidin
Monolayer experiments revealed magainin 2 and indolicidin
to be highly membrane active (Fig. 1), producing significant
increment in surface pressure following their injection un-
derneath lipid films residing on an air/water interface. De-
pending on film composition, critical packing densities cor-
responding to surface pressures c were found above which
these peptides could no longer interact with the monolayers
in a manner producing increase in  (Verger and Pattus,
1976). Although both peptides intercalated into zwitterionic
phosphatidylcholine monolayers, they interact preferen-
tially with acidic phospholipids, in keeping with their net
cationic charge (Matsuzaki et al., 1991, 1993, 1995a, 1998;
Ladokhin et al., 1997). Yet, the impact of PG on their
penetration was significantly different, with a crossover
point at a surface pressure of 38 mN/m being evident for
indolicidin, the slopes for  versus 0 becoming steeper in
the presence of PG (Fig. 1). In contrast, the slopes for 
versus 0 for the penetration of magainin 2 remained unal-
tered by the presence of PG (Fig. 1 A). Our data suggest that
magainin 2 attaches more superficially with the monolayer,
its penetration depth being increased by PG and progres-
sively reduced with increasing surface pressure, with the
angle of its long axis with respect to the layer plane remain-
ing relatively unaltered at different pressures. The above
mode of interaction of magainin 2 with lipid monolayers
would be compatible 1) with its predominately -helical
conformation, the degree of -helicity being increased by
PG (Wieprecht et al., 1997), and 2) the shallow penetration
of this peptide into lipid bilayers with its long axis parallel
to the layer plane (Bechinger et al., 1993; Matsuzaki et al.,
1994). At   c magainin 2 may still associate electro-
statically with the PG in the monolayer, although without
penetrating into the film and thus causing no increment in .
Finally, our data also suggest that unlike in bilayers, ma-
gainin 2 would not adopt the vertical orientation (i.e., the
long axis of its -helix perpendicular to the layer plane) in
lipid monolayers.
For all monolayer compositions tested the values of c
for indolicidin exceeded those measured for magainin 2
(Fig. 1 C), revealing effective insertion and intercalation of
this peptide between the acyl chains. The crossover point at
38 mN/m for indolicidin is of interest. Below the latter
surface pressure the increment in surface pressure 
caused by indolicidin was augmented in the presence of PG
whereas the opposite was observed at higher initial lipid
packing densities. Intriguingly, the crossover point remains
virtually unaltered irrespective of lipid composition (i.e.,
presence of PG), thus suggesting that it could be solely
determined by surface pressure, irrespective of electrostatic
interactions. A possible mechanism is that at 0 38 mN/m
indolicidin changes its orientation in the monolayer in a
pressure-dependent manner, perhaps from a parallel to per-
pendicular orientation of its long axis with respect to the
layer plane (Fig. 9, B and C), thus reducing the area/peptide
and decreasing . Furthermore, it is also possible that
some PG molecules that are electrostatically bound to in-
dolicidin become oriented differently from the phospholip-
ids in the monolayer. In other words, indolicidin with its
associated PG would form a supramolecular complex, the
orientation of which would be pressure dependent. This is
schematically illustrated in Fig. 9. Importantly, the pro-
posed reorientation of peptide-attached phospholipids
would be compatible with the recently suggested model in
which part of the surface of the pore traversing the bilayer
FIGURE 8 HMC microscopy images of giant liposomes in the presence
of cholesterol (Xchol  0.1) following application of indolicidin onto their
surface. The images were recorded before (A) and 5 s after (B) the addition
of 0.2 fmol of indolicidin, respectively. The length of the scale bar in D
corresponds to 20 m.
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would be constituted by lipid headgroups (Ludtke et al.,
1996).
Impact of magainin 2 and indolicidin on bilayer
lipid dynamics
Although distinct differences were revealed by fluorescence
spectroscopy in the effects of magainin 2 and indolicidin on
lipid dynamics, also several similarities were evident. Ac-
cordingly, increment in DPH anisotropy r showed that both
peptides cause an increase in acyl chain order in the pres-
ence of the acidic phospholipid, the magnitude of this effect
increasing with XPG (Figs. 3 B and 5 B). Likewise, efficient
quenching of pyrene fluorescence by both peptides was
evident in the presence of cholesterol (Figs. 2 A and 4 A).
This may relate to the suggested interaction between the OH
group of cholesterol and residue E19 of magainin (Tytler et
al., 1995), with a transmembrane orientation of the peptide
in the membrane. At Xchol  0.1, augmented values of r
were due to indolicidin whereas magainin was without
effect. This suggests that also in the presence of cholesterol,
indolicidin may adopt a transbilayer orientation, its long
axis perpendicular to the plane of the bilayer.
The mechanisms of quenching of the pyrene-labeled
phospholipid analogs by the two antimicrobial peptides are
of interest. -Cation interactions could be involved (Dough-
erty, 1996), the latter being represented by the basic resi-
dues of the peptides. Indolicidin has a high content of Trp
(39%), which could promote its partitioning into the lipid
bilayer (Wimley and White, 1996). Accordingly, also -
interactions between pyrene and Trp are possible. It has
been demonstrated that Trp can quench fluorescence emis-
sion of various pyrene derivatives in micellar solutions
(Encinas and Lissi, 1986; Altamirano et al., 1998). An
additional possibility is chain reversal (Holopainen et al.,
1999) causing accommodation of the pyrene moiety into a
more polar environment upon the binding of the peptide to
the lipid bilayer, thus increasing the polarity of the micro-
environment of the fluorophore and causing decrement in
quantum yield.
In addition to the above similarities, also pronounced
differences between the two peptides were evident when the
effects of the acidic phospholipid on lipid dynamics were
investigated with the pyrene-labeled lipid analogs. Ma-
gainin 2 caused significant quenching of the pyrene emis-
sion for LUVs composed of zwitterionic phospholipids
(Fig. 2 A). However, in the presence of PG, the monomer
intensity of pyrene increased, the magnitude of this effect
being progressively augmented with XPG (Fig. 2 A). Circular
dichroism, Raman, Fourier transform infrared, and solid-
state nuclear magnetic resonance studies show that ma-
gainin adopts an -helical conformation upon binding to
lipid bilayers (Matsuzaki et al., 1989, 1991; Williams et al.,
1990; Jackson et al., 1992; Bechinger et al., 1993; Wie-
precht at al., 1997; Hirsh et al., 1996). These different
effects of magainin 2 on the two membranes may be due to
1) quenching of pyrene fluorescence by direct contacts with
the positively charged groups of the peptide, e.g., the
-amino group of lysine, or 2) the microenvironment of the
fluorophore being changed by the -helical peptide residing
inserted into the bilayer, parallel to the layer plane, as
outlined above. In the presence of PG, however, the positive
charges of the peptide should be neutralized upon electro-
static complex formation with the acidic phospholipid, thus
reducing the quenching of pyrene fluorescence due to -cat-
ion interactions.
FIGURE 9 Model depicting the interactions of indolicidin with lipid
monolayers and bilayers. (A—C) Association of indolicidin with lipid
monolayers; (D and E) Interaction of indolicidin with lipid bilayers in. The
filled spheres represent the negatively charged lipid headgroups, and the
open spheres represent the zwitterionic lipid headgroups. The molecules of
indolicidin are illustrated as small cylinders.
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Interestingly, in the presence of the acidic phospholipid,
the magainin/lipid molar ratios at which the initial incre-
ment in Im leveled off were 1:21, 1:16, and 1:12.5, corre-
sponding to XPG  0.1, 0.2, and 0.4 (Fig. 2 A), yielding
magainin/PG stoichiometries of 1:2, 1:3, and 1:5, respec-
tively. In parallel, the initial increment in r for DPH leveled
off at magainin/lipid molar ratios of1:30, 1:12, and 1:5 (at
XPG  0.1, 0.2, and 0.4, respectively), corresponding to
approximate magainin/PG stoichiometries of 1:3, 1:2.5, and
1:2 (Fig. 3). At these peptide/lipid molar ratios, magainin
has been reported to insert into acidic-phospholipid-contain-
ing membranes (Ludtke et al., 1994). Moreover, it has been
shown that the orientation of the -helix of magainin in a
bilayer depends on the peptide:lipid molar ratios, and at the
above stoichiometries the helices should insert perpendicu-
lar to the membrane surface, forming pores in PG-contain-
ing membranes (Ludtke et al., 1996). The pores have been
suggested to be composed of not only the polar face of the
amphiphilic helices but also of the polar headgroup of the
lipids, with the inner and outer monolayers being continu-
ous via these pore-lining lipids. This structure in the mem-
brane may reduce the polarity of the microenvironment for
the pyrene moiety of the probes and thus increase its quan-
tum yield. Interestingly, the values for Ie/Im were progres-
sively decreased by magainin 2 at XPG  0.1 (Fig. 3 A), in
keeping with the enhanced acyl chain order diminishing the
rate of lipid lateral diffusion. Yet, as r was increased by
magainin 2 already at XPG  0.1, with no changes in Ie/Im,
we may conclude that both enrichment of the PPDPG probe
into microdomains as well as reduction in its lateral diffu-
sion are taking place.
Similarly to magainin 2, the membrane association of
indolicidin with anionic and zwitterionic vesicles was quite
different (Figs. 1 B, 4, and 5), in keeping with previous
equilibrium dialysis studies (Ladokhin et al., 1997).
Whereas quenching of pyrene fluorescence revealed parti-
tioning of indolicidin into a SOPC bilayer it had little effect
on membrane acyl chain order (Fig. 5). Instead, the inter-
action of indolicidin with anionic membranes causes aug-
mented lipid acyl chain order, evident as an increase in DPH
fluorescence anisotropy and with sigmoidal dependence on
XPG (Fig. 5). In contrast to magainin 2, indolicidin caused
significant and parallel decrease in both pyrene monomer
and excimer emission intensities, independently from lipid
composition, and with minor changes in Ie/Im (Fig. 4).
Accordingly, enrichment of the acidic PG into microdo-
mains is induced by indolicidin. Interestingly, below in-
dolicidin/lipid molar ratio of 1:20, pyrene Im decreased in
the sequence XPG 0.4
 0.2
 0.1
 0 (Fig. 4 A), whereas
at indolicidin/lipid molar ratio of 1:10 the dependence of the
decrement in Im on XPG was reversed. A possible mecha-
nism for this change could be the following. At low peptide/
lipid molar ratio indolicidin appears to become accommo-
dated into the bilayer interface (Ladokhin et al., 1997), with
chain reversal (Holopainen et al., 1999) of the pyrene-
labeled chain bringing this moiety closer to the bilayer
surface and thus allowing its contact with the basic residues
of indolicidin. The latter would thus cause collisional
quenching of the pyrene moiety by -cation interactions.
However, with increasing XPG we can expect electrostatic
binding of PG headgroups to the basic residues of indolici-
din, thus preventing direct contacts between pyrene and the
cationic residues of indolicidin. As the membrane binding
of indolicidin is augmented in a cooperative manner with
increasing peptide concentration, the reversal of the effi-
ciency in quenching could involve clustering of the lipid-
peptide complexes in the bilayer. Quenching of pyrene by
indolicidin would therefore be less in acidic-phospholipid-
containing membranes. When the concentration of indolici-
din increases above the peptide/lipid ratio of 1:10, the
peptide would incorporate in a highly cooperative manner
within the acyl chain region of the membrane (Ha et al.,
2000) (Fig. 9 E), whereas in neutral membranes it locates in
the interface (Fig. 9 D). The amount of inserted indolicidin
would depend on XPG in the bilayer, causing the quenching
by Trp residues of indolicidin to dominate, in keeping with
the pronounced decrement in Im at XPG  0.4 (Fig. 4 A).
Effects of magainin 2 and indolicidin on
giant liposomes
Cytoplasmic membrane permeabilization is considered to
be responsible for the antimicrobial action of peptides such
as magainin and indolicidin (Matsuzaki, 1998, 1999; Sit-
aram and Nagaraj, 1999), and several models for its mech-
anism have been proposed (for a review, see Bechinger,
1999). Pore or channel formation has been suggested to
cause dissipation of transmembrane potential and lipid
asymmetry (Falla et al., 1996; Matsuzaki, 1998, 1999; Sit-
aram and Nagaraj, 1999). Magainin 2 and indolicidin should
insert into the lipid bilayers as defined structures, in a
conformation with all hydrophobic amino acids constituting
one surface that then contacts the hydrophobic core of the
membrane. Membrane insertion of these peptides thus
forces the phospholipid acyl chains apart. The antimicrobial
actions of these peptides may also include local phase
transitions, such as the separation of lipid-peptide micelles
from the bilayers, or local changes of the membrane curva-
ture due to the intercalating peptides, which could cause a
local collapse of the bilayer structure. On a molecular level
these processes could be underlying the vesiculation of
giant vesicles induced by magainin 2 and indolicidin re-
ported here. The lytic activity of magainin is highly sensi-
tive to the lipid composition of the target membrane, and
this peptide preferentially binds to and permeabilizes anion-
ic-lipid-containing membranes (Matsuzaki et al., 1991,
1993, 1995a, 1998). Accordingly, magainin at concentra-
tions lethal to microorganisms does not lyse mammalian
cells, which do not contain negatively charged phospholip-
ids in the outer monolayer of their plasma membrane (Ma-
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tsuzaki, 1999). The exposure of E. coli to magainin causes
blebs on the bacterial surface (Matsuzaki et al., 1997). In the
present study, vesiculation of giant liposomes induced by
magainin 2 and indolicidin was observed, representing more
macroscopic changes of their binding to lipid bilayers. Im-
portantly, the presence of the acidic PG was required for
vesiculation by both peptides. Vesiculation of giant lipo-
somes required repeated applications of magainin 2 and thus
imply a concentration-dependent mechanism of action. It
has been demonstrated that the pores formed in the presence
of magainin are transient, with a finite lifetime (Matsuzaki
et al., 1995b). Upon disintegration of nearby pores, a su-
pramolecular complex of peptides and lipids may form, thus
causing transient disruption of the bilayer (Fig. 6). Simul-
taneously, some of the peptide molecules should translocate
into the inner leaflet of the membrane (Matsuzaki et al.,
1995a, 1996), allowing the membrane to reorganize and
heal. Formation of endocytotic vesicles due to magainin 2 is
more pronounced than exocytosis (Fig. 6), which may relate
to the asymmetric application of the peptide onto the outer
surface of the bilayer. Accordingly, the vesiculation of the
giant liposome could relieve the bilayer from unfavorable
strain due to the asymmetrical peptide binding and subse-
quent membrane expansion. Vesiculation can be expected
to decrease the peptide concentration in the remaining giant
liposome membrane and thus attenuate pore formation.
Subsequently, continued addition of magainin 2 to the
membrane is needed to cause further vesiculation of the
giant liposome (Fig. 6).
Indolicidin contains only 13 amino acids and as such is
too short to span the bilayer. Yet, the peptide could span the
bilayer as an aggregate or a head-to-tail dimer with associ-
ated acidic phospholipids (Fig. 9 E), inducing membrane
instability. It has been shown that indolicidin is capable of
killing Gram-negative bacteria by crossing the outer mem-
brane as well as causing disruption of the cytoplasmic
membrane, with the formation of channels (Falla et al.,
1996). Compared with the effects of magainin 2 the smaller
size of the endocytotic vesicles induced by indolicidin (Fig.
7) may reflect different modes of interaction of these pep-
tides with lipids. Some of the indolicidin molecules may
translocate into the inner leaflet of the membrane. In addi-
tion to its broad spectrum of antifungal and antibacterial
activities, indolicidin is also toxic to mammalian cells
(Schluesener et al., 1993; Ahmad et al., 1995). Interestingly,
the effects of indolicidin on SOPC and SOPC-cholesterol
giant liposomes differ. The underlying cause is uncertain at
this stage and could relate to the impact of cholesterol on the
bilayer structure as well as on the orientation of indolicidin
in the membrane. Further studies are thus needed to eluci-
date the effect of cholesterol on the membrane binding of
indolicidin.
Our results show that the effects of magainin 2 on the
biomembrane models used were significantly enhanced in
the presence of the negatively charged phospholipid. In
addition to the negative membrane charge, also the peptide/
lipid stoichiometry has been shown to be an important
determinant for the organization of magainin in bilayers
(Ludtke et al., 1994). At low peptide/lipid ratio, the -he-
lical peptide lies essentially parallel to the membrane sur-
face and shallowly penetrating into the hydrophobic core of
the membrane (Bechinger et al., 1993; Matsuzaki et al.,
1994). This location pushes the lipid headgroups aside,
forcing a gap to form in the hydrophobic region, while the
membrane becomes thinner to fill the gap (Ludtke et al.,
1995). The transient nature of the pores formed by magainin
has been emphasized previously (Matsuzaki et al., 1995b).
It is possible that the local and transient disruption of the
membrane requires asymmetric binding of the peptide to the
target cell membrane. Accordingly, immediately following
the binding of magainin to the outer leaflet of the target cell
plasma membrane bilayer the lateral pressure of this outer
monolayer increases compared with the inner leaflet. More-
over, the superficial location of the -helices parallel to the
layer plane imposes curvature strain in the outer monolayer,
causing positive spontaneous curvature. When the magni-
tude of lateral pressure difference between the two leaflets
and energy associated with the positive spontaneous curva-
ture exceed the energy needed for membrane deformation,
the bilayer is destabilized and reorientation of the peptide to
vertical orientation with respect to layer plane takes place,
with opening of pores. These pores may subsequently ag-
gregate into supramolecular structures inside the target, as
observed in giant liposomes (Fig. 6). The pores and the
destabilized state would thus be transient, allowing healing
of the bilayer. To this end, magainin 2 contains a cluster of
positive charges approximately in the middle of its se-
quence. It is possible that also when this peptide is forming
the transient pore in bilayers and is oriented perpendicular
to the membrane plane, these cationic residues would be
electrostatically bound to PG, similarly to the organization
proposed here for indolicidin (Fig. 9). A major difference in
lipid composition of membranes between prokaryotic and
eukaryotic cells is that the latter are abundant in cholesterol
(Op den Kamp, 1979). The above mechanism would also be
compatible with the presence of cholesterol preventing the
membrane-perturbing action of magainin 2. More specifi-
cally, cholesterol has been shown to transfer (flip-flop) very
fast between the two leaflets of human plasma membrane
(Lange et al., 1981). Accordingly, this rapid translocation of
cholesterol could abolish the generation of difference in the
lateral pressure of the inner and outer leaflet of the target
membrane following the binding of magainin 2 into the
latter monolayer. Therefore, significantly higher amounts of
magainin 2 would be needed to achieve toxic effects by this
peptide in eukaryotic cells compared with bacterial targets
(Zasloff, 1987). The equilibrium lateral pressure in the outer
leaflet of the eukaryotic plasma membranes has been esti-
mated to be 32 mN/m (Demel et al., 1975). The observed
highly efficient penetration of indolicidin into monolayers
Magainin and Indolicidin: Binding to Lipids 2989
Biophysical Journal 81(5) 2979–2991
at pressures exceeding 34 mN/m may explain in part the
lytic action of this peptide in eukaryotic cells. Moreover, the
outer leaflet of mammalian plasma membranes is exclu-
sively composed of zwitterionic phospholipids, whereas
bacterial membranes contain large amounts of negatively
charged PG (Op den Kamp, 1979). Accordingly, because of
the lack of negative charges and high pressure only weak
interaction of magainin 2 with eukaryotic plasma membrane
would be expected whereas the much more efficiently in-
tercalating indolicidin would be able to perturb the organi-
zation of eukaryotic bilayers. The lipid specificity could
thus contribute to the different toxicities of these two pep-
tides.
CONCLUSIONS
As the detailed mechanisms of action of antimicrobial pep-
tides remain to be elucidated, it was of interest to compare
the effects on model biomembranes of two structurally
unrelated peptides, indolicidin and magainin 2. Although
their conformations are different and the length of the
former is approximately one half of that of the latter, they
also share features such as net positive charge and am-
phiphilicity, causing them to associate with phospholipid
membranes. This interaction is further enhanced by acidic
phospholipids, which are probably important to their anti-
microbial activity. Acidic phospholipids were required for
the vesiculation of giant liposomes by these peptides, and
they both cause segregation of acidic phospholipids, com-
plexing them into supramolecular clusters. Likewise, both
peptides increase acyl chain order. All these effects are in
keeping with cooperative membrane association being nec-
essary for their antimicrobial action, presumably involving
transient transmembrane orientation of the peptides. It may
further be that their antimicrobial action requires the ini-
tially asymmetric exposure of the target membranes to these
peptides and relates to the relaxation of the system back to
thermodynamic equilibrium.
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